Disruption of sphingolipid metabolism and induction of equine leukoencephalomalacia by Fusarium proliferatum culture material containing fumonisin B2 or B3

Environmental Toxicology and Pharmacology

Volumn 3, Issue 3, 1997, Pages 221-228

  Riley, Ronald T ^a   Showker, Jency L ^a   Owens, Debra L ^b   Ross, P Frank ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Equine leukoencephalomalacia; Fumonisin; Fusarium montiliforme; Fusarium proliferatum; Sphingolipids

Indexed keywords

FUMONISIN B2; FUMONISIN B3; SPHINGANINE; SPHINGOLIPID; SPHINGOSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DIET; ENZYME BLOOD LEVEL; FUSARIUM; HORSE; LEUKOENCEPHALOPATHY; LIPID METABOLISM; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030793148     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(97)00015-X     Document Type: Article

References (33)

1. Ballou, L.R., Laulederkind, S.L.F., Rosloniec, E.F., Raghow, R., 1996. Ceramide signalling and the immune response. Biochim. Biophys. Acta 1301, 273.
2. Bielawska, A., Crane, H.M., Liotta, D., Obeid, L.M., Hannun, Y.A., 1993. Selectivity of ceramide-mediated biology: lack of activity of erythro-dihydroceramide. J. Biol. Chem. 268, 26226.
3. Butler, T., 1902. Notes on a feeding experiment to produce leucoencephalitis in a horse, with positive results. Am. Vet. Rev. 26, 748.
4. Chmura, S.J., Nodzenski, E., Weichselbaum, R.R., Quintans, J., 1996. Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingolmyelinase. Cancer Res. 56, 2711.
5. 1 on protein and lipid synthesis in primary rat hepatocytes. Food Chem. Toxicol. 34, 361.
6. Jarvis, D.W., Fornari, F.A., Traylor, R.S., Martin, H.A., Krammer, L.B., Erukulla, R.K., Bittman, R., Grant, S., 1996. Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J. Biol. Chem. 271, 8275.
7. 1, Onderstepoort. J. Vet. Res. 57, 269.
8. 1 isolated from Fusarium moniliforme, Onderstepoort. J. Vet. Res. 55, 197.
9. Merrill, A.H. Jr., Wang, E., Mullins, R.E., Charles, W., Jamison, L., Nimkars, S., Liotta, D.C., 1988. Quantitation of free sphingosine in liver by high performance liquid chromatography. Anal. Biochem. 171, 373.
10. 1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J. Biol. Chem. 268, 27299.
11. Merrill, A.H., Jr., Wang, E., Gilchrist D.G., Riley, R.T., 1993b. Fumonisins and other inhibitors of de novo sphingolipid biosynthesis. In: Bell, R.M., Hannun, Y.A., Merrill, A.H. Jr. (Eds.), Advances in Lipid Research: Sphingolipids and Their Metabolites, Vol. 26. Academic Press, Orlando, FL, p. 215.
12. Merrill, A.H., Jr., Liotta, D.C., Riley, R.T., 1996a. Bioactive properties of sphingosine and structurally related compounds. In: Bell, R.M. (Ed.), Handbook of Lipid Research: Lipid Second Messengers, Vol. 8. Plenum Press, New York, p. 205.
13. Merrill, A.H. Jr., Liotta, D.C., Riley, R.T., 1996b. Fumonisins: fungal toxins that shed light on sphingolipid function. Trends Cell Biol. 6, 218.
14. Merrill, A.H. Jr., Schmelz, E.-M., Dillehay, D.L., Spiegel, S., Shayman, J.A., Schroeder, J.J., Riley, R.T., Voss, K.A., Wang, E., 1997. Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 142, 208.
15. National Institute of Health, 1985, Guide for Care and Use of Laboratory Animals, NIH publication no. 88-23.
16. National Veterinary Services Laboratories Developmental Project Final Report, 1995, Toxicity of fumonisins in horses equine leukoencephalomalacia (ELEM)), Identification No PL/TC/94-2.
17. Nimkar, S., Menaldino, D., Merrill, A.H. Jr., Liotta, D.C., 1988. A stereoselective synthesis of sphingosine, a protein kinase C inhibitor. Tetrahedron Lett. 29, 3037.
18. 1 alters sphingolipid metabolism and disrupts the barrier function of endothelial cells in culture. Toxicol. Appl. Pharmacol. 133, 343.
19. Riley, R.T., An, A.H., Showker, J.L., Yoo, H.-S., Norred, W.P., Chamberlain, W.J., Wang, E., Merrill, A.H. Jr., Motelin, G., Beasley, V.R., Haschek, W.M., 1993. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicol. Appl. Pharmacol. 118, 105.
20. 1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity. J. Nutr. 124, 594.
21. Riley, R.T., Wang, E., Merrill, A.H. Jr., 1994b. Liquid chromatography of sphinganine and sphingosine: use of sphinganine to sphingosine ratio as a biomarker for consumption of fumonisins. J. Assoc. Off. Anal. Chem. Int. 77, 533.
22. Riley, R.T., Wang, E., Schroeder, J.J., Smith, E.R., Plattner, R.D., Abbas, H., Yoo, H.-S., Merrill, A.H. Jr., 1996. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat. Toxins 4, 3.
23. Ross, P.F., Nelson, P.E., Richard, J.L., Osweiler, G.D., Rice, L.D., Plattner, R.D., Wilson, T.M., 1990. Production of fumonisins by Fusarium moniliforme and Fusarium proliferatum isolates associated with equine leukoencephalomalacia and a pulmonary edema syndrome in swine. Appl. Environ. Microbiol. 56, 3225.
24. 1 in feeds associated with animal health problems. Mycopathologia 114, 129.
25. Ross, P.F., Ledet, A.E., Owens, D.L., Rice, L.G., Nelson, H.A., Osweiler, G.D., Wilson, T.M., 1993. Experimental equine leukoencephalomalacia, toxic hepatosis, and encephalopathy caused by corn naturally contaminated with fumonisins. J. Vet. Diagn. Invest. 5, 69.
26. 2 in cultured Fusarium proliferatum, M-6104, causes equine leukoencephalomalacia. J. Vet. Diagn. Invest. 6, 263.
27. Smith, E.R., Merrill, A.H. Jr., 1995. Differential roles of de novo sphingolipid biosynthesis and turnover in the burst of free sphingosine and sphinganine, and their 1-phosphates and N-acyl-derivatives, that occurs upon changing the medium of cells in culture. J. Biol. Chem. 270, 18749.
28. 1 in rats and mice. Nat. Toxins 4, 16.
29. Wang, E., Norred, W.P., Bacon, C.W., Riley, R.T., Merrill, A.H. Jr., 1991. Inhibition of sphingolipid biosynthesis by fumonisins: implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266, 14486.
30. Wang, E., Ross, P.F., Wilson, T.M., Riley, R.T., Merrill, A.H. Jr., 1992. Alteration of serum sphingolipids upon dietary exposure of ponies to fumonisins, mycotoxins produced by Fusarium moniliforme. J. Nutr. 122, 1706.
31. Wilson, T.M., Ross, P.F., Owens, D.L., Rice, L.G., Green, S.A., Jenkins, S.J., Nelson, H.A., 1992. Experimental reproduction of ELEM - a study to determine the minimum toxic dose in ponies. Mycopathologia 117, 115.
32. 1. J. Biol. Chem. 270, 13171.
33. Yoo, H.-S., Norred, W.P., Showker, J.L., Riley, R.T., 1996. Elevated sphingoid bases and complex sphingolipid depletion contributing factors in fumonisin-induced cytotoxicity. Toxicol. Appl. Pharmacol. 138, 211.